These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23671592)

  • 1. Changing risk behaviours and the HIV epidemic: a mathematical analysis in the context of treatment as prevention.
    Ramadanovic B; Vasarhelyi K; Nadaf A; Wittenberg RW; Montaner JS; Wood E; Rutherford AR
    PLoS One; 2013; 8(5):e62321. PubMed ID: 23671592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada.
    Lima VD; Hogg RS; Montaner JS
    PLoS One; 2010 Jun; 5(6):e10991. PubMed ID: 20539817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.
    Lima VD; Johnston K; Hogg RS; Levy AR; Harrigan PR; Anema A; Montaner JS
    J Infect Dis; 2008 Jul; 198(1):59-67. PubMed ID: 18498241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.
    Montaner JS; Lima VD; Barrios R; Yip B; Wood E; Kerr T; Shannon K; Harrigan PR; Hogg RS; Daly P; Kendall P
    Lancet; 2010 Aug; 376(9740):532-9. PubMed ID: 20638713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.
    Bezemer D; de Wolf F; Boerlijst MC; van Sighem A; Hollingsworth TD; Prins M; Geskus RB; Gras L; Coutinho RA; Fraser C
    AIDS; 2008 May; 22(9):1071-7. PubMed ID: 18520351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.
    Alistar SS; Owens DK; Brandeau ML
    PLoS Med; 2011 Mar; 8(3):e1000423. PubMed ID: 21390264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV treatment as prevention among people who inject drugs - a re-evaluation of the evidence.
    Fraser H; Mukandavire C; Martin NK; Hickman M; Cohen MS; Miller WC; Vickerman P
    Int J Epidemiol; 2017 Apr; 46(2):466-478. PubMed ID: 27524816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of local epidemic conditions in monitoring progress towards HIV epidemic control in Kenya: a modelling study.
    Anderson SJ; Garnett GP; Enstone J; Hallett TB
    J Int AIDS Soc; 2018 Nov; 21(11):e25203. PubMed ID: 30485720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015.
    Olding M; Enns B; Panagiotoglou D; Shoveller J; Harrigan PR; Barrios R; Kerr T; Montaner JSG; Nosyk B
    J Int AIDS Soc; 2017 Sep; 20(1):21941. PubMed ID: 28953322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding access to HAART: a cost-effective approach for treating and preventing HIV.
    Johnston KM; Levy AR; Lima VD; Hogg RS; Tyndall MW; Gustafson P; Briggs A; Montaner JS
    AIDS; 2010 Jul; 24(12):1929-35. PubMed ID: 20588171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.
    Nosyk B; Min JE; Lima VD; Hogg RS; Montaner JS;
    Lancet HIV; 2015 Sep; 2(9):e393-400. PubMed ID: 26423553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users: 7-year follow up.
    Vincent E; Bouhnik AD; Carrieri MP; Rey D; Dujardin P; Granier F; Fuzibet JG; Obadia Y; Moatti JP; Spire B;
    AIDS; 2004 Jun; 18(9):1321-5. PubMed ID: 15362665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
    Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
    BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of steady and casual partnerships to the incidence of HIV infection among homosexual men in Amsterdam.
    Xiridou M; Geskus R; De Wit J; Coutinho R; Kretzschmar M
    AIDS; 2003 May; 17(7):1029-38. PubMed ID: 12700453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is use of antiretroviral therapy among homosexual men associated with increased risk of transmission of HIV infection?
    Stephenson JM; Imrie J; Davis MM; Mercer C; Black S; Copas AJ; Hart GJ; Davidson OR; Williams IG
    Sex Transm Infect; 2003 Feb; 79(1):7-10. PubMed ID: 12576605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection.
    Dukers NH; Goudsmit J; de Wit JB; Prins M; Weverling GJ; Coutinho RA
    AIDS; 2001 Feb; 15(3):369-78. PubMed ID: 11273217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV treatment as prevention among injection drug users.
    Wood E; Milloy MJ; Montaner JS
    Curr Opin HIV AIDS; 2012 Mar; 7(2):151-6. PubMed ID: 22227587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is HAART modifying the HIV epidemic?
    Maggiolo F; Leone S
    Lancet; 2010 Aug; 376(9740):492-3. PubMed ID: 20638714
    [No Abstract]   [Full Text] [Related]  

  • 20. Vets, denialists and rememberers: social typologies of patient adherence and non-adherence to HAART from the perspective of HIV care providers.
    Orchard T; Salters K; Palmer A; Michelow W; Lepik KJ; Hogg R
    AIDS Care; 2015; 27(6):758-61. PubMed ID: 25635938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.